Young people with substance use disorders had worse mental health than substance-using peers without a disorder

Comparing 51 youth with a current SUD to 21 without a lifetime SUD diagnosis, those with SUD endorsed more severe depressive and anxiety symptoms, lower quality of life and role functioning, more alcohol-related problems, and higher frequency cannabis use. They also had higher risk scores for alcohol, tobacco, cannabis, cocaine, amphetamines, and hallucinogens. No group differences emerged for social/occupational functioning or subjectively rated sleep quality.

Baseline data from the INTEGRATE clinical trial. 79 participants aged 12-25 with high-prevalence mental illness and substance use recruited from headspace primary mental health centres in North-Western Melbourne. Self-report and interview measures of psychiatric diagnoses, symptoms, functioning, and substance use.

Youth mental health services frequently encounter substance use but may not distinguish between use and disorder. This study shows the clinical gap between the two is substantial, with SUD-diagnosed youth carrying heavier psychiatric and functional burdens that require integrated treatment approaches.

The high overlap between substance use disorders and mental illness in young people supports integrated early intervention models. Treating either condition in isolation likely misses the compounding effects of comorbidity.

Small sample (n=79) with only 21 in the comparison group. Baseline cross-sectional data cannot establish causal direction. Recruited from a specific Melbourne region, limiting generalizability. Secondary analysis of trial data, not designed primarily for this comparison.